Mifamurtide for high-grade, resectable, nonmetastatic osteosarcoma following surgical resection: a cost-effectiveness analysis. [electronic resource]
Producer: 20140210Description: 1123-32 p. digitalISSN:- 1524-4733
- Acetylmuramyl-Alanyl-Isoglutamine -- administration & dosage
- Adjuvants, Immunologic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Bone Neoplasms -- drug therapy
- Cost-Benefit Analysis
- Humans
- Markov Chains
- Osteosarcoma -- drug therapy
- Phosphatidylethanolamines -- administration & dosage
- Quality-Adjusted Life Years
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.